The headache community is more than ready for a preventive migraine drug that works. Click through these slides for highlights of recently published trials.
There is a good deal of misinformation available about migraine headaches. Which of these 10 statements are myth and which are fact?
This month’s Special Report post-test allows you to gauge how much you have learned about current approaches to treating migraine headache.
Monoclonal antibodies that inhibit calcitonin gene-related peptide could revolutionize preventive migraine therapy. Here's what you need to know.
Headaches that occur several days before menses as well as disabling headaches on days unrelated to menses... how would you help this young woman?
If the goal of headache therapy for adolescent migraineurs is a pain-free adult life, here's a road map.
From PAINWeek 2017: Reflex vasodilation is out, neurobiologic dysfunction is in as explanation for migraine etiology.
What Rx for adolescent migraineurs? Ideal care for menstrual migraine? Perfect patient for new CGRP inhibitors? Answers in this PCP Special Report.
Headache was a hot topic at the AAN Annual Meeting, and several studies have added to the literature. This slideshow summarizes the latest.
If you know that the FDA approved onabotulinumtoxinA to treat chronic migraine headache but aren't sure how it works, a neurologist explains.